Clinical Trials Directory

Trials / Completed

CompletedNCT01843764

Rapid Diagnostic Tests for Assessment of Initial Clearance and Detection of Recurrent Malaria Infections

Efficacy of Plasmodium Falciparum Specific Rapid Diagnostic Tests for Assessment of Initial Clearance and Detection of Recurrent Infections After Antimalarial Treatment

Status
Completed
Phase
Study type
Observational
Enrollment
53 (actual)
Sponsor
Anders Björkman · Academic / Other
Sex
All
Age
6 Months – 59 Months
Healthy volunteers
Not accepted

Summary

The aim of the study was to follow clearance of malaria infections and detection of new malaria episodes after initiation of antimalarial treatment in Tanzanian children. For this purpose the investigators used five diagnostic tools, 2 Rapid Diagnostic tests based on Histidine Rich Protein 2(HRP2) and Lactate dehydrogenase(LDH), 2 microscopical methods and one polymerase chain reaction (PCR). The investigators followed the 53 enrolled children during 42 days.

Conditions

Interventions

TypeNameDescription
DEVICEHRP2 and LDH based rapid diagnostic tests for P.falciparum

Timeline

Start date
2009-06-01
Primary completion
2011-04-01
Completion
2012-06-01
First posted
2013-05-01
Last updated
2013-05-03

Locations

2 sites across 1 country: Tanzania

Source: ClinicalTrials.gov record NCT01843764. Inclusion in this directory is not an endorsement.

Rapid Diagnostic Tests for Assessment of Initial Clearance and Detection of Recurrent Malaria Infections (NCT01843764) · Clinical Trials Directory